Gene deleted in colorectal cancer of humans
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 2, 1996
Issued Date -
N/A
app pub date -
Apr 14, 1994
filing date -
Jan 4, 1990
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A new human gene termed DCC is disclosed. Methods and kits are provided for assessing mutations of the DCC gene in human tissues and body samples. Insertion, deletion, and point mutations in DCC are observed in human tumor cells. Normal tissues express DCC while most colorectal cancers do not. Loss of wild-type DCC genes is associated with neoplastic progression and a diminished life expectancy.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully